XEPLION 150 MG, Suspension injectable à libération prolongée en seringue pre-remplie [P]


--- Description
Pack Boite d'une seringue pre-remplie et 2 aiguilles
Strength (Dosage) 150 MG
Laboratory MAPHAR
Ingredients Palipéridone
Therapeutic class Neuroleptique atypique
ATC code N05AX13
PPH $403.90
PPV $432.40
Refundable No
Refund base $0.00
Refund rate $0.00
Table A
Marketing status Commercialized
Type Not specified
Uses Xeplion est indiqué pour le traitement aigu et d'entretien de la schizophrénie.
Side effects

Medications with one or more of the ingredients above

Medications under one or more of the therapeutic classes above

Medications from the same laboratory

The materials provided by this website,, are for informational purposes only and are not provided as legal advice or medical advice. No reader should act on the basis of this material without seeking appropriate professional advice with respect to the particular facts and applicable law. The materials are not presented as correct, complete or up-to-date, and are not a substitute for a visit or consultation with a physician or health professional.